Product Overview
British Dragon Exemestane Tablets contain 25 mg of exemestane, an aromatase inhibitor of the steroidal kind. Where the common non-steroidal inhibitors sit on the enzyme reversibly, this one is accepted by the enzyme as if it were a raw material and then leaves it permanently damaged. The protein has to be replaced before aromatization can resume. Tablets are pressed under GMP conditions and the 25 mg strength on the pack is a full medical dose, which is why so many on-cycle plans call for a half or a quarter of a tablet rather than a whole one.
Because aromatase is the step that turns androgens into estrogens, blocking it lowers estradiol rather than blocking its receptor. The result is a drier look and less of the water layer that builds over a course based on an aromatizing compound such as Testabol Enanthate or Testabol Depot. Where breast tissue has already become sensitive, a receptor-blocking drug such as Tamoxifen Tablets works on a different point of the same problem, and the two are not interchangeable.
The choice between this tablet and Anastrozole Tablets is the choice between irreversible and reversible control. Exemestane leaves a longer tail, so missing a dose matters less and stopping takes longer to wear off; the flip side is that overshooting takes longer to correct. Letrobol Tablets sits above both in raw strength and is held back for cases where the first two are not enough.
Dosage Protocol
The ranges come from the project fact sheet for exemestane. The 25 mg tablet sets the arithmetic, and the every-other-day rhythm follows from the way the drug binds the enzyme.
| Beginner | 12.5 mg every other day for as long as the base cycle runs; a low opening amount selected from a blood result |
| Intermediate | 12.5-25 mg every other day, with the longer action of the irreversible binding taken into account |
| Advanced | 25 mg a day only where aromatization is confirmed high; side effects and dose move together |
| Female | Not a use case for this card; the drug is contraindicated in premenopausal women and is documented here as estrogen control for men on cycle |
| Administration | Oral, commonly on alternate days, with timing built around estradiol results rather than around a fixed schedule |
Protocols With the Base Cycle
This tablet is never a course in itself. It is written into a stack that aromatizes, and the amount is set by what that stack produces.
What to Expect
The first changes are hormonal and arrive inside the first fortnight, but they last longer after the last tablet than the half-life alone would suggest.
- Week one to two. Estradiol falls and the estrogen-driven puffiness and breast tenderness ease off in step with it.
- After the last dose. Because the enzyme stays out of service for several days, the drop in estrogen continues past the point where the drug has cleared from the blood.
- Too far down. Flushes and sweating are the standard signs of a low-estrogen state, and aching joints are the most frequent complaint once the amount is overshot.
- High doses. Amounts beyond the therapeutic range have been recorded with androgenic effects such as acne and some weight gain.
- Limit. The cell-count change seen in oncology treatment, where lymphocyte counts fell in roughly a fifth of patients, is a clinical finding rather than a sports one, but it is a reminder that this is a real drug and not a vitamin.
- Limit two. The tablet manages the result of aromatization and does not switch the production line off at its source, which is what happens only when the base cycle ends.
Side Effects and Management
As with the whole class, the complaints below are mostly the consequence of estrogen sitting too low, and they respond to a smaller amount.
Coming Off the Inhibitor
Exemestane does not shut down the gonadal axis, so it needs no recovery protocol of its own. What it does need is a plan for the point at which it is pulled out of the base cycle.
